Study Identifies Factors Associated With Platinum-induced Ototoxicity in Pediatric Cancer Survivors
- OPACC
- Nov 18, 2016
- 1 min read
Treatment with a higher total cumulative dose of cisplatin, young age, and concomitant furosemide administration are associated with an increased risk of ototoxicity in childhood cancer survivors treated with platinum-based therapy, according to a study published in the European Journal of Cancer.
Comments